We’re excited to announce that we’ll be attending the GIANT Health Event 2024 in London! 🇬🇧 Join us at the Business Design Centre from December 9th-10th, where we’ll be connecting, collaborating, and discussing our groundbreaking Callavid® and Phlovid™ technologies. As the UK’s largest NHS innovation festival, this event is a hub for HealthTech and Innovation. …
Thank you to Barclays for the opportunity to pitch Calla Lily Clinical Care at their inaugural Demo Directory Demo Day held at their Canary Wharf HQ. It was great to be among 16 founders meeting an engaged group of 100+ investors, timely in advance of completing our latest funding round 💪. Grateful to the Barclays …
Grateful to the Virginia Beach Economic Development team for hosting a wonderful reception at the U.S. Embassy. It was a fantastic opportunity to discuss our future U.S. plans while taking in the superb river views from this impressive building. 🏛 With our Callavid® drug delivery technology’s first use indication planned for IVF, it was pertinent …
As the co-founder of Calla Lily Clinical Care, I’m always on the lookout for the latest trends and insights shaping healthcare. And also opportunities to escape my children. Did I mention I have 3 pre-teen/teenagers? Recently, I had the opportunity to attend two distinctly different conferences: PODD (Partnership Opportunities in Drug Delivery) in Boston and …
Today, I had the privilege of presenting Calla Lily Clinical Care’s latest innovation, Callavid®, at the MidAtlantic Capital Conference with PACT in Philadelphia. It’s an exciting step forward in women’s health, particularly for those navigating the challenges of IVF and miscarriage. Our Callavid technology harnesses the power of intravaginal drug delivery initially through our medical …
We had a great 2 days at the Partnerships in Drug Delivery PODD Conference in Boston with team members Professor Andrew Lewis and Dr Lara Zibners representing Calla Lily. Besides Andy’s well received presentation on our Callavid vaginal drug delivery platform, there were also superb connections made with the wider drug delivery technology community, and …
What a privilege it was for Lara and I to present Calla Lily Clinical Care to senior members of Merck Group and M Ventures . Selected out of 100+ women’s health startups from around the world, we were able to share our vision for our transformational Callavid drug delivery platform, beginning with pregnancy & fertility. …
Excited to announce that Calla Lily Clinical Care will be attending the PODD Conference in Boston next week! Our Principal Scientist Andrew Lewis and co-founder Lara Zibners will be showcasing our innovative vaginal drug delivery platform and its numerous applications beginning with pregnancy and fertility, and exploring new partnership opportunities. Stay tuned for updates on …
I feel like Boston is the place to be these days! I made my 3rd trip there in the last year to attend the Women’s Health Innovation Summit in Boston thanks to Kisaco Research and it was inspiring, to say the least. The event assembled leaders, innovators, and passionate professionals all focused on one mission: …
We had an exciting & intense three days at CPHI Milan, connecting with business leaders from across the global life sciences industry, especially those passionate about advancing Womens Health. It was a pleasure to meet with our existing partners in person and explore exciting new materials and suppliers. We also uncovered unique opportunities for collaboration …